(0.14%) 5 253.50 points
(0.07%) 39 669 points
(0.25%) 18 301 points
(0.28%) $78.48
(1.55%) $2.29
(-1.20%) $2 346.40
(-0.49%) $28.37
(0.12%) $1 008.40
(-0.09%) $0.927
(0.25%) $10.86
(-0.02%) $0.798
(-1.39%) $91.38
2 days till quarter result
(amc 2024-05-15)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer...
Stats | |
---|---|
Today's Volume | 49 064.00 |
Average Volume | 254 061 |
Market Cap | 1.84M |
EPS | $-65.90 ( 2024-05-02 ) |
Next earnings date | ( $-1.230 ) 2024-05-15 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.00700 (1.84%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-08 | Goldman Sachs Group Inc | Sell | 72 874 | Common Stock |
2023-11-07 | Goldman Sachs Group Inc | Buy | 0 | Common Stock |
2023-09-12 | Jacob Jeffrey E. | Sell | 275 | Common Stock |
2023-03-27 | Simpson Jennifer K. | Buy | 99 383 | Stock Option (right to buy) |
2023-03-27 | Horvath Susan | Buy | 34 369 | Stock Option (right to buy) |
INSIDER POWER |
---|
61.28 |
Last 76 transactions |
Buy: 2 117 070 | Sell: 358 529 |
Panbela Therapeutics, Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Panbela Therapeutics, Financials
Annual | 2023 |
Revenue: | $0 |
Gross Profit: | $-25.65M (0.00 %) |
EPS: | $-232 430 |
FY | 2023 |
Revenue: | $0 |
Gross Profit: | $-25.65M (0.00 %) |
EPS: | $-232 430 |
FY | 2022 |
Revenue: | $0 |
Gross Profit: | $-35.73M (0.00 %) |
EPS: | $-40 749 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-34.62 |
Financial Reports:
No articles found.
Panbela Therapeutics,
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators